List of Proair Digihaler drug patents
Proair Digihaler is owned by Teva Branded Pharm.
Proair Digihaler contains Albuterol Sulfate.
Proair Digihaler has a total of 22 drug patents out of which 0 drug patents have expired.
Proair Digihaler was authorised for market use on 31 March, 2015.
Proair Digihaler is available in powder, metered;inhalation dosage forms.
The generics of Proair Digihaler are possible to be released after 22 February, 2041.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7540282 | TEVA BRANDED PHARM | Reservoir pressure system for medicament inhaler |
May, 2023
(3 months from now) | |
| US10765820 | TEVA BRANDED PHARM | Dry powder inhalation apparatus |
May, 2025
(2 years from now) | |
| US9463288 | TEVA BRANDED PHARM | Dry powder inhalation apparatus |
May, 2025
(2 years from now) | |
| US8651103 | TEVA BRANDED PHARM | Dry powder inhalation apparatus |
Mar, 2028
(5 years from now) | |
| US10022510 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(8 years from now) | |
| US9731087 | TEVA BRANDED PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(8 years from now) | |
| US10124131 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(8 years from now) | |
| US9216260 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jun, 2031
(8 years from now) | |
| US10561808 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(8 years from now) | |
| US8978966 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jan, 2032
(8 years from now) | |
| US9782550 | TEVA BRANDED PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(12 years from now) | |
| US9782551 | TEVA BRANDED PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(12 years from now) | |
| US10918816 | TEVA BRANDED PHARM | Compliance monitoring module for a breath-actuated inhaler |
Dec, 2035
(12 years from now) | |
| US10569034 | TEVA BRANDED PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2036
(13 years from now) | |
| US11351317 | TEVA BRANDED PHARM | Drug delivery device with electronics |
Feb, 2038
(15 years from now) | |
| US11357935 | TEVA BRANDED PHARM | Drug delivery device with electronics |
Sep, 2038
(15 years from now) | |
| US11000653 | TEVA BRANDED PHARM | Inhaler |
Dec, 2038
(15 years from now) | |
| US11344685 | TEVA BRANDED PHARM | Drug delivery device with electronics |
Sep, 2039
(16 years from now) | |
| US11439777 | TEVA BRANDED PHARM | Drug delivery device with electronics |
May, 2040
(17 years from now) | |
| US11464923 | TEVA BRANDED PHARM | Inhaler system |
Jun, 2040
(17 years from now) | |
| US11173259 | TEVA BRANDED PHARM | Drug delivery device with electronics and power management |
Jul, 2040
(17 years from now) | |
| US11266796 | TEVA BRANDED PHARM | Inhalation device with integrated electronics |
Feb, 2041
(18 years from now) | |
Drugs and Companies using ALBUTEROL SULFATE ingredient
Market Authorisation Date: 31 March, 2015
Treatment: NA
Dosage: POWDER, METERED;INHALATION
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic